BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17602911)

  • 1. Antimicrobial resistance prevention initiative--an update: proceedings of an expert panel on resistance.
    Moellering RC; Graybill JR; McGowan JE; Corey L
    Am J Med; 2007 Jul; 120(7):S4-25; quiz S26-8. PubMed ID: 17602911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial resistance prevention initiative--an update: proceedings of an expert panel on resistance.
    Moellering RC; Graybill JR; McGowan JE; Corey L;
    Am J Infect Control; 2007 Nov; 35(9):S1-23; quiz S24-6. PubMed ID: 17980231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological factors influencing the emergence of antimicrobial resistance.
    Cohen ML
    Ciba Found Symp; 1997; 207():223-31; discussion 231-7. PubMed ID: 9189644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on antimicrobial chemotherapy: 2. The mechanisms of antibiotic resistance.
    Smith A; Bagg J
    Dent Update; 1998 Jun; 25(5):203-4, 206-8. PubMed ID: 18170955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
    Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
    Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial resistance in major pathogens of hospital-acquired pneumonia in Asian countries.
    Lagamayo EN
    Am J Infect Control; 2008 May; 36(4 Suppl):S101-8. PubMed ID: 18468549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The emergence of viruses resistant to antiviral agents: a new challenge].
    Boivin G
    Union Med Can; 1993; 122(1):31-6. PubMed ID: 8465473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving problems with resistant pathogens.
    Chastre J
    Clin Microbiol Infect; 2008 Apr; 14 Suppl 3():3-14. PubMed ID: 18318874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The battle against multi-resistant strains: Renaissance of antimicrobial essential oils as a promising force to fight hospital-acquired infections.
    Warnke PH; Becker ST; Podschun R; Sivananthan S; Springer IN; Russo PA; Wiltfang J; Fickenscher H; Sherry E
    J Craniomaxillofac Surg; 2009 Oct; 37(7):392-7. PubMed ID: 19473851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteremia in previously hospitalized patients: prolonged effect from previous hospitalization and risk factors for antimicrobial-resistant bacterial infections.
    Chen SY; Wu GH; Chang SC; Hsueh PR; Chiang WC; Lee CC; Ma MH; Hung CC; Chen YC; Su CP; Tsai KC; Chen TH; Chen SC; Chen WJ
    Ann Emerg Med; 2008 May; 51(5):639-46. PubMed ID: 18353506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug resistance in the treatment of invasive fungal infections].
    Nordøy I; Gaustad P
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2607-11. PubMed ID: 19023376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing prevalence of methicillin resistance in serious ocular infections caused by Staphylococcus aureus in the United States: 2000 to 2005.
    Asbell PA; Sahm DF; Shaw M; Draghi DC; Brown NP
    J Cataract Refract Surg; 2008 May; 34(5):814-8. PubMed ID: 18471638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of 28 antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) from a clinical setting in Malaysia.
    Neela V; Sasikumar M; Ghaznavi GR; Zamberi S; Mariana S
    Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):885-92. PubMed ID: 19058585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One reservoir: redefining the community origins of antimicrobial-resistant infections.
    Silbergeld EK; Davis M; Leibler JH; Peterson AE
    Med Clin North Am; 2008 Nov; 92(6):1391-407, xi. PubMed ID: 19061758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streptococcus pneumoniae: does antimicrobial resistance matter?
    Lynch JP; Zhanel GG
    Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of resistance: a goal for dose selection for antimicrobial agents.
    Drusano GL
    Clin Infect Dis; 2003 Jan; 36(Suppl 1):S42-50. PubMed ID: 12516029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of Staphylococcus aureus isolated from skin and wound infections in the United States 2005-07: laboratory-based surveillance study.
    Tillotson GS; Draghi DC; Sahm DF; Tomfohrde KM; Del Fabro T; Critchley IA
    J Antimicrob Chemother; 2008 Jul; 62(1):109-15. PubMed ID: 18397923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility testing and resistance phenotype detection in Staphylococcus aureus strains isolated from patients with atopic dermatitis, with apparent and recurrent skin colonization.
    Kedzierska A; Kapińska-Mrowiecka M; Czubak-Macugowska M; Wójcik K; Kedzierska J
    Br J Dermatol; 2008 Dec; 159(6):1290-9. PubMed ID: 18795934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbial spectrum and antibiotic susceptibility profile of gram-positive aerobic bacteria isolated from cancer patients.
    Ashour HM; el-Sharif A
    J Clin Oncol; 2007 Dec; 25(36):5763-9. PubMed ID: 18089873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economics of antibiotic resistance.
    Sipahi OR
    Expert Rev Anti Infect Ther; 2008 Aug; 6(4):523-39. PubMed ID: 18662118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.